| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HORIZON PHARMA PLC | 1,751,322 | 25,885,000 | 4.10% | ||
| 2 | Esperion Therapeutics Inc | 543,347 | 19,186,000 | 3.04% | ||
| 3 | BIOGEN INC | 68,000 | 18,593,000 | 2.94% | ||
| 4 | GLAUKOS CORP | 325,800 | 16,714,000 | 2.65% | ||
| 5 | AMGEN INC | 100,000 | 16,407,000 | 2.60% | ||
| 6 | INCYTE CORP | 115,000 | 15,372,000 | 2.43% | ||
| 7 | ABIOMED INC | 117,048 | 14,654,000 | 2.32% | ||
| 8 | MEDTRONIC PLC | 181,115 | 14,591,000 | 2.31% | ||
| 9 | REGENERON PHARMACEUTICALS | 37,000 | 14,338,000 | 2.27% | ||
| 10 | LILLY ELI & CO | 170,000 | 14,299,000 | 2.26% | ||
| 11 | ALLERGAN PLC | 59,000 | 14,096,000 | 2.23% | ||
| 12 | GILEAD SCIENCES INC | 206,916 | 14,054,000 | 2.23% | ||
| 13 | EXELIXIS INC | 630,000 | 13,652,000 | 2.16% | ||
| 14 | ALEXION PHARMACEUTIC | 111,702 | 13,543,000 | 2.14% | ||
| 15 | INTRA-CELLULAR THERAPIES INC | 715,664 | 11,630,000 | 1.84% | ||
| 16 | ENDOLOGIX INC | 1,600,000 | 11,584,000 | 1.83% | ||
| 17 | CELGENE CORP | 93,000 | 11,572,000 | 1.83% | ||
| 18 | PFIZER INC | 335,422 | 11,475,000 | 1.82% | ||
| 19 | NEKTAR THERAPEUTICS COM | 470,000 | 11,031,000 | 1.75% | ||
| 20 | BIOMARIN PHARMACEUTICAL INC | 125,000 | 10,973,000 | 1.74% | ||
| 21 | BRISTOL MYERS SQUIBB CO | 201,000 | 10,930,000 | 1.73% | ||
| 22 | UNITEDHEALTH GROUP INC | 65,000 | 10,661,000 | 1.69% | ||
| 23 | NEVRO CORP COM | 112,614 | 10,552,000 | 1.67% | ||
| 24 | VERTEX PHARMACEUTICALS INC | 95,013 | 10,390,000 | 1.65% | ||
| 25 | CVS HEALTH CORP | 130,000 | 10,205,000 | 1.62% | ||
| 26 | MERCK & CO INC | 160,000 | 10,166,000 | 1.61% | ||
| 27 | CIGNA CORPORATION | 64,000 | 9,375,000 | 1.48% | ||
| 28 | HCA HOLDINGS INC | 104,707 | 9,318,000 | 1.48% | ||
| 29 | JAZZ PHARMACEUTICALS PLC | 60,320 | 8,754,000 | 1.39% | ||
| 30 | KITE PHARMA INCORPORATED | 110,000 | 8,634,000 | 1.37% | ||
| 31 | ZIMMER BIOMET HLDGS INC | 70,000 | 8,548,000 | 1.35% | ||
| 32 | ABBVIE INC | 130,000 | 8,471,000 | 1.34% | ||
| 33 | ALKERMES PLC | 140,409 | 8,214,000 | 1.30% | ||
| 34 | SUPERNUS PHARMACEUTICALS INC | 230,000 | 7,199,000 | 1.14% | ||
| 35 | ALNYLAM PHARMACEUTICALS INC | 130,000 | 6,663,000 | 1.06% | ||
| 36 | AETNA INC NEW | 52,000 | 6,633,000 | 1.05% | ||
| 37 | HUMANA INC | 32,000 | 6,596,000 | 1.04% | ||
| 38 | HOLOGIC INC | 150,000 | 6,383,000 | 1.01% | ||
| 39 | EXPRESS SCRIPTS HLDG CO | 96,000 | 6,327,000 | 1.00% | ||
| 40 | CENTENE CORP DEL | 87,593 | 6,242,000 | 0.99% | ||
| 41 | XENCOR INC COM | 260,000 | 6,219,000 | 0.98% | ||
| 42 | ANTHEM INC | 37,468 | 6,196,000 | 0.98% | ||
| 43 | THERMO FISHER SCIENTIFIC INC | 40,000 | 6,144,000 | 0.97% | ||
| 44 | CARDINAL HEALTH INC | 75,000 | 6,116,000 | 0.97% | ||
| 45 | DYNAVAX TECHNOLOGIES CORP | 984,696 | 5,859,000 | 0.93% | ||
| 46 | EDWARDS LIFESCIENCES CORP | 60,000 | 5,644,000 | 0.89% | ||
| 47 | AMERISOURCEBERGEN CORP | 63,000 | 5,576,000 | 0.88% | ||
| 48 | SAGE THERAPEUTICS INC | 72,659 | 5,164,000 | 0.82% | ||
| 49 | ABBOTT LABS | 115,000 | 5,107,000 | 0.81% | ||
| 50 | LION BIOTECHNOLOGIES INC COM | 650,000 | 4,843,000 | 0.77% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-17-000651, filed 2017.04.19).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
